ResMed | RMD - Market Capitalization

Stock Price
201.88
Daily Change
-0.58 -0.29%
Monthly
-10.16%
Yearly
-19.79%
Q2 Forecast
197.82

ResMed reported $30.02B in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Ansell USD 3.36B 450.92M Dec/2025
Artivion USD 2.18B 176M Dec/2025
AtriCure USD 1.43B 12M May/2026
Baxter International USD 8.67B 1.15B Mar/2026
Cochlear AUD 17.05B 2.6B Dec/2025
Cooper Companies USD 15.95B 2.05B Dec/2025
CSL USD 55.89B 20.42B Dec/2025
Dexcom USD 24.17B 1.72B Mar/2026
Edwards Lifesciences USD 46.17B 3.3B Mar/2026
Fisher Paykel Healthcare NZD 21.76B 2.1B Dec/2025
Globus Medical USD 11.52B 172M May/2026
Haemonetics USD 2.66B 1.1B May/2026
Idexx Laboratories USD 45.08B 449M May/2026
Insulet USD 10.58B 3.96B May/2026
Integra LifeSciences USD 1.04B 306M May/2026
Intuitive Surgical USD 163.73B 37.04B Mar/2026
Masimo USD 9.44B 85M May/2026
Philips EUR 21.43B 1.05B May/2026
Ramsay Health Care AUD 7.93B 537.83M Dec/2025
ResMed USD 32.7B 2.46B Mar/2026
Sigma Healthcare AUD 2.77B 1.91B May/2026
Sonic Healthcare AUD 11.17B 1.7B Dec/2025
Steris USD 19.95B 1.74B May/2026
Teleflex USD 6.2B 901M May/2026
Thermo Fisher Scientific USD 182.66B 35.04B Mar/2026